ARCHIVES

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 3 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

Highlights of Dingell Hearing: Statements Of Visco, Testimony By Broder On Fisher, Uterine Cancer Deaths

April 22, 1994

Trading In Stock Of U.S. Bioscience Halted, Newsletter Report Cited

October 9, 1992

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

December 26, 2014

Virus Cancer Program Report On Scientific Activities

August 1, 1975

Robert Weinburger, Ernst Wynder Win Top Milken Awards

November 2, 1990

FDA’s Jane Henney

February 11, 1994